Assessment of the distribution segment of the Russian pharmaceutical market

The distribution segment remains an important element of the pharmaceutical market, since distributors are resellers engaged in the wholesale trade of pharmaceutical products. The role of distributors in the market is to carry out the movement of goods from producers to end consumers. The deterioration of the economic situation in the last few years has led to a change in the main market trends, while the distribution segment is no exception. The study evaluates the state of the Russian distribution segment in 2019-2023, identifies current trends and their causes. It was found that the distribution segment of the pharmaceutical market continues to be characterized by high concentration, since the top three representatives account for more than 45% of sales, the top 5 - more than 59%, and the top 10 - 77% by the end of 2023. An assessment of the dynamics of sales volume using the example of 10 leaders of the pharmaceutical market distribution segment showed that the overall situation is stable and market leaders maintain their positions. Pulse, Protek and Katren remain the largest distributors, each accounting for 14-15% of total sales in 2023. Despite the stagnation of the market after the end of the pandemic, the distribution segment has not undergone significant changes and the trends of previous years remain.